Hepion Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $109 | $0 |
Gross Profit | -30 | |||
EBITDA | -4,458 | -8,503 | -5,787 | |
EBIT | -5,818 | |||
Net Income | -4,865 | -3,925 | -2,853 | -11,059 |
Net Change In Cash | 0 | 0 | 109 | 0 |
Free Cash Flow | -2,517 | -10,928 | -3,616 | -9,002 |
Cash | 1,497 | 2,115 | 13,105 | 14,785 |
Basic Shares | 6,718 | 5,799 | 5,072 | 4,818 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -67 | -77 | -86 | -34 |
EBITDA | -49,258 | -43,540 | -30,317 | -20,111 |
EBIT | -49,325 | -43,617 | -30,403 | -20,146 |
Net Income | -48,926 | -42,200 | -32,722 | -20,353 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -40,112 | 26,803 | ||
Free Cash Flow | -40,903 | -34,977 | -31,354 | -16,253 |
Cash | 14,785 | 51,189 | 91,348 | 40,726 |
Basic Shares | 3,970 | 3,811 | 3,514 | 483 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.72 |
2024-06-30 | -$0.67 |
2024-03-31 | -$2.42 |
2023-12-31 | -$2.42 |
